| Cell therapy in patients with COVID-19 using Wharton’s jelly mesenchymal stem cells: a phase 1 clinical trial M Saleh, AA Vaezi, R Aliannejad, AA Sohrabpour, SZF Kiaei, ... Stem cell research & therapy 12, 1-13, 2021 | 78 | 2021 |
| Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review F Hosseinzadeh, J Verdi, J Ai, S Hajighasemlou, I Seyhoun, F Parvizpour, ... Cancer Cell International 18, 1-12, 2018 | 33 | 2018 |
| Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma I Seyhoun, S Hajighasemlou, S Muhammadnejad, J Ai, M Nikbakht, ... Journal of Cellular Physiology 234 (6), 9495-9503, 2019 | 22 | 2019 |
| Therapeutic approach of adipose-derived mesenchymal stem cells in refractory peptic ulcer M Saleh, AA Sohrabpour, MR Mehrabi, I Seyhoun, AA Vaezi Stem Cell Research & Therapy 12, 1-9, 2021 | 17 | 2021 |
| Novel combination of mesenchymal stem cell-conditioned medium with sorafenib have synergistic antitumor effect of hepatocellular carcinoma cells I Seyhoun, S Hajighasemlou, J Ai, F Hosseinzadeh, M Mirmoghtadaei, ... Asian Pacific Journal of Cancer Prevention: APJCP 20 (1), 263, 2019 | 17 | 2019 |
| Sorafenib and mesenchymal stem cell therapy: a promising approach for treatment of HCC S Hajighasemlou, M Nikbakht, S Pakzad, S Muhammadnejad, ... Evidence‐Based Complementary and Alternative Medicine 2020 (1), 9602728, 2020 | 13 | 2020 |
| Natural killer cell expansion with autologous feeder layer and anti-CD3 antibody for immune cell therapy of hepatocellular carcinoma F Hosseinzadeh, J Ai, S Ebrahimi-Barough, I Seyhoun, A Hajifathali, ... Asian Pacific Journal of Cancer Prevention: APJCP 20 (12), 3797, 2019 | 13 | 2019 |
| Recent advances in mesenchymal stem/stromal cells (MSCs)‐based approaches for osteoarthritis (OA) therapy A Hassanzadeh, N Vousooghi, R Rahimnia, E Razeghian, S Rajaeian, ... Cell Biology International 47 (6), 1033-1048, 2023 | 12 | 2023 |
| Development and clinical application of tumor-derived exosomes in patients with cancer J Verdi, N Ketabchi, N Noorbakhsh, M Saleh, S Ebrahimi‐Barough, ... Current stem cell research & therapy 17 (1), 91-102, 2022 | 12 | 2022 |
| Chemo-immune cell therapy by intratumoral injection of adoptive NK cells with capecitabine in gastric cancer xenograft model Z Ghazvinian, S Abdolahi, M Ahmadvand, AH Emami, S Muhammadnejad, ... BioImpacts: BI 13 (5), 383, 2022 | 5 | 2022 |
| Anti‐inflammatory effect of mesenchymal stem cells on hepatocellular carcinoma in the xenograft mice model S Hajighasemlou, M Nikbakht, S Pakzad, A Azadbakht, ... Veterinary Medicine and Science 8 (5), 2086-2091, 2022 | 3 | 2022 |
| The effects of Sorafenib and Natural killer cell co-injection in combinational treatment of hepatocellular carcinoma; an in vivo approach F Hosseinzadeh, J Ai, A Hajifathali, S Muhammadnejad, ... Pharmacological Reports 74 (2), 379-391, 2022 | 3 | 2022 |
| Implication for prevention and control of cardiovascular disease; an experience from Iran S Hozhabri, I Seyhoun, S Sandoogh Daran, M Saqaee, M Shadnosh, ... Scientific Journal of Kurdistan University of Medical Sciences 26 (5), 119-125, 2021 | 2 | 2021 |
| Cell therapy using anti-NKG2A pretreated natural killer cells in patients with hepatocellular carcinoma S Tavakoli, MS Salavati, S Abdolahi, J Verdi, I Seyhoun, N Vosoughi, ... Advanced Pharmaceutical Bulletin, -, 2024 | | 2024 |
| The Iranian National Guideline for Cell Therapy and Regenerative Medicine J Verdi, M Shadnoush, G Janbabai, A Shoae-Hassani, ... Regenerative Engineering and Translational Medicine 8 (3), 370-376, 2022 | | 2022 |
| Activation of natural killer cells with interleukin 21 in the treatment of preclinical Neuroblastoma model A Shoae Hassani, M Shadnoush, H Kazemi, N Vosughi, R Mohseni, ... Feyz Medical Sciences Journal 25 (3), 1009-1019, 2021 | | 2021 |
| The Effects of Sorafenib and Natural Killer Cell Co-injection in Combinational Treatment of Hepatocellular Carcinoma; In Vivo F Hosseinzadeh, J Ai, A Hajifathali, S Muhammadnejad, ... | | 2021 |
| Research Article Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC S Hajighasemlou, M Nikbakht, S Pakzad, S Muhammadnejad, ... | | 2020 |
jafar AiTissue Engineering and Applied Cell Sciences Department-School of Advanced Technologies in Medicine在 tums.ac.ir 的电子邮件经过验证
